The New York State Education Department's State Board for Physical Therapy has recognized Relias Learning, LLC as an approved provider of physical therapy and physical therapy assistant continuing education. This activity is approved for 1.50 contact hours.
This activity is provided by The Texas Board of Physical Therapy Examiners Accredited Provider #1902008TX and meets continuing competence requirements for physical therapist and physical therapist assistant licensure renewal in Texas.
This course is not approved as meeting the ethics and professional requirements for Texas physical therapists or physical therapist assistants.
The assignment of Texas PT CCUs does not imply endorsement of specific course content, products, or clinical procedures by TPTA or TBPTE. This activity is approved for 1.50 contact hours.
Oklahoma Physical Therapy Advisory Committee has approved this course under Category B. Approval # 202111166. This activity is approved for 1.50 contact hours.
This course is approved by the Minnesota Board of Physical Therapy for 1.50 Category 1 credits and offered to PTs and PTAs for CEUs.
This course has been approved by the Nevada State Board of Physical Therapy Examiners. This activity is approved for 1.50 contact hours.
Outline:
NSAID use
The Eicosinoids
Prostaglandin Activities
Medical Uses
Physiological Basis for Pharmacological Activity
NSAID Activity
Adverse Effects
Tylenol
Mechanisms in Overdose
Symptops in Tylenol Overdose
Asperin
Dosage in Overdose
Mechnaism of Overdose
Symptoms in ASA Overdose
Aspirin and Asthma
Asthma and ASA Intolerance
Asthma Effect
Common Members of the NSAID Families
What Did Research from 1999 to 2004 Demonstrate?
Potential Interaction Types
Pharmacokinetic interactions
Decreased Absorption of NSAIDs
Protein Binding
Asperin Protein Binding
Digoxin protein binding
Hepatic P450 Interactions
CYP2C9
Fluconazole
Rifampicin
Warfarin and CYP2C9
Warfarin Pharmacogenomics
Allele
Warfarin
CYP2D6
Coversion of Prodrug to Active Drug
CYP3A4
Renal Elimination
Pharmacodynamic
Inhibition of Renal Prostaglandins
Increased Risk of Nephrotoxicity
Increased GI Bleed
NSAID Summary
References
A Professor Emeritus in the Department of Nursing at California State University in Long Beach, CA, Dr. Callahan received her nursing education at Rockingham Community College, Wentworth, North Carolina, and her anesthesia education at the Anesthesia Program for Nurses at North Carolina Baptist Hospital, Bowman Gray School of Medicine, Winston Salem, North Carolina. The recipient of a BS in Biology from Guilford College in Greensboro, North Carolina, a MA in Education, and a MS in Nursing from California State University in Long Beach, California, she received her PhD in Educational Research and Evaluation from Florida State University, Tallahassee, Florida in 1994. In the summer of 2003, Dr .Callahan was a fellow in the Genetics Institute of the National Institute of Nursing Research/National Institutes of Health, Bethesda, Maryland. Dr. Callahan has a broad base of practice experience as an educator, clinician, administrator, and consultant. She has written numerous publications and is widely known as a continuing education lecturer in the field of anesthesia, pain management, and the sciences. She is a Past-President of the American Association of Nurse Anesthetists. Dr. Callahan remains clinically active, and enjoys teaching both in the college classroom as well as her nationally presented seminars. Disclosure: Linda L. Callahan, CRNA, PhD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.